ARCHIVES

NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity

This article is from The Cancer Letter archive.

Vol. 07 No. 09 | February 27, 1981

Download PDF Visit The Full Archive

Related Articles

ACS names new officers.

December 5, 2003

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

Columbia To Host U.S.- China Conference

February 15, 1980

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005

Final Regulations For Clinical Cancer Education Program Adopted

October 3, 1975

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009